Streptomycin: Clinical Trials

8 trials of Streptomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 terminated. 2 Not applicable, 2 Phase 2, 2 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 22Completed 2
Phase 32Completed 2
Early Phase 11Terminated 1

Follow Streptomycin: new trials by email Literature Review of Streptomycin trials Research Report on Streptomycin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague
Ciprofloxacin, Streptomycin, Gentamicin - Plague, Bubonic, Plague, Pneumonic
Phase 3CompletedUniversity of Oxford2222020-02-152025-03-06
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
anti-tuberculosis drug - Tuberculosis
RecruitingBeijing Children's Hospital8002018-07-012018-08-15
Patients Response to Early Switch To Oral:Osteomyelitis Study
oral antibiotics, intravenous antibiotics - Osteomyelitis
Early Phase 1TerminatedJulio Ramirez112014-03-062021-04-06
Efficacy of Intestinal Decontamination in Patients Colonized by Carbapenem-resistant Klebsiella Pneumoniae and Colistin
Neomycin, Streptomycin, Gentamicins - Patients Colonized by Klebsiella Pneumoniae.
CompletedMaimónides Biomedical Research Institute of Córdoba442012-07-012015-11-13
Treatment and Diagnosis of Plague
gentamicin, streptomycin - Plague
Phase 2 / Phase 3CompletedCenters for Disease Control and Prevention1142004-08-012009-02-26
Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis
paromomycin, streptomycin - Tuberculosis, Pulmonary
Not applicableCompletedFDA Office of Orphan Products Development241994-11-012015-03-25
Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease
amithiozone, clarithromycin, ethambutol - Mycobacterium Avium-intracellulare Infection
Phase 2CompletedNational Jewish Health501991-01-012015-03-25
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
Cycloserine, Ethionamide, Capreomycin sulfate - HIV Infections, Tuberculosis
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)5252021-11-03

Conditions studied

Tuberculosis (3)  ·  Bacterial Infections (2)  ·  Communicable Diseases (2)  ·  Immune System Diseases (2)  ·  Mycobacterium Infections (2)  ·  Plague (2)  ·  Rare Diseases (2)  ·  Tuberculosis, Pulmonary (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)  ·  Mycobacterium avium-intracellulare Infection (1)  ·  Osteomyelitis (1)

Sponsors

Beijing Children's Hospital (1)  ·  Centers for Disease Control and Prevention (1)  ·  FDA Office of Orphan Products Development (1)  ·  Julio Ramirez (1)  ·  Maimónides Biomedical Research Institute of Córdoba (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Jewish Health (1)  ·  University of Oxford (1)

Countries

Madagascar (2)  ·  United States (2)  ·  China (1)

Top investigators

A-Dong Shen, Master (1)  ·  Benson C (1)  ·  Charles Arthur Peloquin (1)  ·  Chirgwin K (1)  ·  David Seligson, MD (1)  ·  Julio Ramirez, MD (1)  ·  Kevin Griffith, MD, MPH (1)  ·  Martin Schriefer, PhD (1)  ·  Peter W Horby, MD (1)  ·  Sepkowitz K (1)  ·  Telzak E (1)  ·  Thomas Paul Kanyok (1)  ·  Wei Zhao, Doctor (1)  ·  Yu-Jie Qi, Master (1)

Results publications

PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 27494911, PMID 32807214, PMID 38970065, PMID 40768716, PMID 4902833, PMID 8948280